Recital 5, Regulation (EU) 2018/613

In forcesince 20 Apr 2018cited 2×

According to those opinions, biocidal products of product-types 2 and 4 containing PHMB (1415; 4.7) may be expected to satisfy the criteria of Article 19(1)(b) of Regulation (EU) No 528/2012, provided that certain specifications and conditions concerning their use are complied with.

  • Judgment of the General Court (Seventh Chamber) of 15 September 2021. Laboratoire Pareva and Biotech3D Ltd & Co. KG v European Commission.Decision

    Also on 20 April 2018, the Commission adopted Implementing Regulation (EU) 2018/613 approving PHMB (1415; 4.7) as an existing active substance for use in biocidal products of product-types 2 and 4 (OJ 2018 L 102, p. 1) (‘the contested …

    15 Sep 2021 · 62018TJ0337

  • Judgment of the Court (Eighth Chamber) of 10 November 2022. Laboratoire Pareva v European Commission.Decision

    On the same day, the Commission adopted the regulation at issue. As is apparent from recital 5 of that regulation, the Commission considered that biocidal products of product-types 2 and 4 could be expected to satisfy the requirements of …

    10 Nov 2022 · 62021CJ0702